The kinetic stability of MHC class II: Peptide complexes is a key parameter that dictates immunodominance

被引:180
|
作者
Lazarski, CA
Chaves, FA
Jenks, SA
Wu, SH
Richards, KA
Weaver, JM
Sant, AJ
机构
[1] Univ Rochester, David H Smith Ctr Vaccine Biol & Immunol, Aab Inst Biomed Sci, Dept Microbiol & Immunol, Rochester, NY 14642 USA
[2] Univ Chicago, Div Biol Sci, Comm Immunol, Chicago, IL 60637 USA
关键词
D O I
10.1016/j.immuni.2005.05.009
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
T cell priming to exogenous antigens reflects regulated antigen processing in dendritic cells, subsequent homing to lymph nodes, sustained interactions between T cells and antigen-bearing dendritic cells, and, ultimately, selective T cell activation and differentiation. In this study, we test the hypothesis that an intrinsic property of the class II:peptide complex is a key determinant that dictates the specificity of an emerging CD4 T cell response. We found that immunodominant peptides possess extremely long half-lives with class II molecules (t(1/2) > 150 hr), whereas cryptic peptides displayed half-lives of less than 10 hr. Furthermore, and most importantly, by using a peptide shuttle vector and four independent antigens, we demonstrate a direct, causative relationship between the half-life of peptide epitopes and their immunogenicity in vivo. Taken collectively, our results suggest the half-life of class II:peptide complexes is the primary parameter that dictates the ultimate hierarchy of the elicited T cell response.
引用
收藏
页码:29 / 40
页数:12
相关论文
共 50 条
  • [21] Immunogenicity of tumor peptides: importance of peptide length and stability of peptide/MHC class II complex
    Ursula Grohmann
    Maria Laura Belladonna
    Roberta Bianchi
    Ciriana Orabona
    Silvia Silla
    Giuseppe Squillacioti
    Maria Cristina Fioretti
    Paolo Puccetti
    Cancer Immunology, Immunotherapy, 1999, 48 : 195 - 203
  • [22] Ii-Key/MHC class II apitope hybrids: a strategy that enhances MHC class II epitope loading to create more potent peptide vaccines
    Kallinteris, Nikoletta L.
    Lu, Xueqing
    Blackwell, Catherine E.
    von Hofe, Eric
    Humphreys, Robert E.
    Xu, Minzhen
    EXPERT OPINION ON BIOLOGICAL THERAPY, 2006, 6 (12) : 1311 - 1321
  • [23] A three-step kinetic mechanism for peptide binding to MHC class II proteins
    Joshi, RV
    Zarutskie, JA
    Stern, LJ
    BIOCHEMISTRY, 2000, 39 (13) : 3751 - 3762
  • [24] DISTINCT KINETIC STATES OF MHC CLASS II-PEPTIDE INTERACTION CORRELATE WITH DISTINCT CLASS-II STRUCTURES
    SADEGHNASSERI, S
    STERN, L
    WILEY, D
    GERMAIN, R
    JOURNAL OF CELLULAR BIOCHEMISTRY, 1993, : 73 - 73
  • [25] Increasing the potency of MHC class II-presented epitopes by linkage to Ii-Key peptide
    Humphreys, RE
    Adams, S
    Koldzic, G
    Nedelescu, B
    von Hofe, E
    Xu, M
    VACCINE, 2000, 18 (24) : 2693 - 2697
  • [26] Peptide Channeling: The Key to MHC Class I Immunosurveillance?
    Yewdell, Jonathan W.
    Dersh, Devin
    Fahraeus, Robin
    TRENDS IN CELL BIOLOGY, 2019, 29 (12) : 929 - 939
  • [27] Peptide loading in the endoplasmic reticulum accelerates trafficking of peptide:MHC class II complexes in B cells
    Morkowski, S
    Raposo, G
    Geuze, HJ
    Rudensky, AY
    JOURNAL OF BIOMEDICAL SCIENCE, 1999, 6 (01) : 53 - 63
  • [28] Class II MHC peptide loading by the professionals
    Bryant, P
    Ploegh, H
    CURRENT OPINION IN IMMUNOLOGY, 2004, 16 (01) : 96 - 102
  • [29] Association of MHC class II-peptide complexes with plasma membrane lipid microdomains
    Poloso, NJ
    Roche, PA
    CURRENT OPINION IN IMMUNOLOGY, 2004, 16 (01) : 103 - 107
  • [30] MHC class II complexes sample intermediate states along the peptide exchange pathway
    Wieczorek, Marek
    Sticht, Jana
    Stolzenberg, Sebastian
    Guenther, Sebastian
    Wehmeyer, Christoph
    El Habre, Zeina
    Alvaro-Benito, Miguel
    Noe, Frank
    Freund, Christian
    NATURE COMMUNICATIONS, 2016, 7